ANI Pharmaceuticals ANIP Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ANI Pharmaceuticals's change in AP?
- ANI Pharmaceuticals (ANIP) reported change in AP of $5.36M in Q1 2026.
- How has ANI Pharmaceuticals's change in AP changed year-over-year?
- ANI Pharmaceuticals's change in AP decreased by 3.4% year-over-year, from $5.55M to $5.36M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.